At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Efficacy and Safety of Washed Microbiota Transplantation for Allergic Rhinitis: A Randomized, Double-blind, Placebo-controlled Study
In Brief
A clinical study evaluating Washed Microbiota Transplantation and Placebo for Rhinitis, Allergic. Not yet recruiting, targeting 32 participants across 1 site.
Detailed Summary
Allergic rhinitis (AR) is characterized by sneezing, nasal congestion, nasal itching and nasal leakage and is caused by immunoglobulin E (IgE)-mediated reactions to inhaled allergens. Increasing evidence showed that gut microbiota could influence the development of AR, and we found that washed microbiota transplantation (WMT) could improve nasal symptoms in clinical practice. This clinical trial aims to evaluate the efficacy and safety of WMT for AR.
Study Details
Timeline
Interventions
Patients take four capsules containing washed microbiota once a day for five consecutive days
Patients take four capsules in the same packaging as the experimental group once a day for five consecutive days